+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Therapeutics, Tools, Banks), Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation), and Region with Growth Forecasts, 2025-2030- Product Image
Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Therapeutics, Tools, Banks), Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation), and Region with Growth Forecasts, 2025-2030- Product Image
New

Regenerative Medicine Market Size, Share & Trends Analysis Report by Product (Therapeutics, Tools, Banks), Therapeutic Category (Dermatology, Musculoskeletal, Immunology & Inflammation), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 245 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4375420
Description Jump to:
The Regenerative Medicine Market was valued at USD 35.47 billion in 2024, and is projected to reach USD 90.01 billion by 2030, rising at a CAGR of 16.83%. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.

Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2019 according to the data published by PhRMA,. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.

Technological advancements such as stem cells, tissue engineering, and nanotechnology has made regenerative medicines a highly interdisciplinary in field. Stem cells are undifferentiated cells, which have the capability to repair and/or regenerate into other cells such as cartilage, tendons, ligaments, muscle, and bones. In July 2021, BlueRock Therapeutics received FDA approval for its pluripotent stem cell-derived dopaminergic neuron therapy, DA01, for advanced Parkinson’s disease treatment. This approval was expected to expand the company’s offerings.

Several key players are taking strategic initiatives such as new product development, strategic alliances, and others have contributed to the regenerative medicine market growth. For instance, in November 2021, Astellas Pharma, Inc. entered into an agreement with Pantherna Therapeutics GmbH to study mRNA-based regenerative medicine. Under this initiative, Astellas' high drug discovery capabilities and Pantherna's state-of-the-art mRNA platform will be used to promote research on developing a new program. In addition, in May 2021, Bayer AG entered into a collaboration with Senti Bio for gene circuit-engineered cell therapies development for regenerative medicine.

Regenerative Medicine Market Report Highlights

  • The therapeutics segment held the largest share in the regenerative medicine market, owing to the growing aging population coupled with an increasing rate of age-related disorders.
  • The rise in a number of clinical trials for stem cell and tissue-based regenerative therapies along with an increase in demand for regenerative therapies is expected to positively influence the growth of the market.
  • Stem cell and progenitor cell-based therapies are projected to witness significant growth owing to huge investments in the R&D space and a growing number of stem cell banks
  • North America dominated the market in 2024 owing to the presence of a significant number of research organizations and universities which are working on R&D of stem cell-based therapies.
  • Asia-Pacific is anticipated to witness the fastest growth in the coming years owing to the rapid adoption of cell-based methods in the healthcare industry.
  • By therapeutic category, the oncology segment dominated the segment in 2024 owing to the increasing cases of cancer globally which is rising the demand for better solutions. The growing number of robust pipelines is driving the market growth

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Therapeutic Category
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.2.1. Market Dynamics
3.2.1.1. Presence of a strong pipeline and a large number of clinical trials
3.2.1.2. High economic impact of regenerative medicine
3.2.1.3. Emerging applications of gene therapy in regenerative medicine
3.2.1.4. Increasing government & private funding to support the development of regenerative medicine
3.2.1.5. Technological advancements in regenerative medicine (stem cell, tissue engineering, and nanotechnology)
3.2.1.6. Increase in strategic partnerships to accelerate the development & commercialization of regenerative medicines
3.2.1.7. Rising prevalence of chronic diseases & genetic disorders, degenerative diseases, and bone & joint diseases leading to a rise in demand for regenerative treatments
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of treatment
3.2.2.2. Regulatory issues pertaining to stem cells, tissue engineering, and regenerative medicines
3.3. Business Environment Analysis
3.3.1. PESTEL Analysis
3.3.2. Porter’s Five Forces Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Segment Dashboard
4.2. Global Regenerative Medicine Market: Product Movement Analysis
4.3. Therapeutics
4.3.1. Therapeutics Market, 2018-2030 (USD Million)
4.3.2. Primary Cell-Based Therapeutics
4.3.2.1. Primary Cell-Based Therapeutics Market, 2018-2030 (USD Million)
4.3.2.2. Dermatology
4.3.2.2.1. Dermatology Market, 2018-2030 (USD Million)
4.3.2.3. Musculoskeletal
4.3.2.3.1. Musculoskeletal Market, 2018-2030 (USD Million)
4.3.2.4. Surgical
4.3.2.4.1. Surgical Market, 2018-2030 (USD Million)
4.3.2.5. Dental
4.3.2.5.1. Dental Market, 2018-2030 (USD Million)
4.3.2.6. Others
4.3.2.6.1. Others Market, 2018-2030 (USD Million)
4.3.3. Stem Cell & Progenitor Cell-based therapeutics
4.3.3.1. Stem Cell & Progenitor Cell-based therapeutics Market, 2018-2030 (USD Million)
4.3.3.2. Autologous
4.3.3.2.1. Autologous Market, 2018-2030 (USD Million)
4.3.3.3. Allogenic
4.3.3.3.1. Allogenic Market, 2018-2030 (USD Million)
4.3.3.4. Others
4.3.3.4.1. Others Market, 2018-2030 (USD Million)
4.3.4. Cell-based Immunotherapies
4.3.4.1. Cell-based Immunotherapies Market, 2018-2030 (USD Million)
4.3.5. Gene Therapies
4.3.5.1. Gene Therapies Market, 2018-2030 (USD Million)
4.4. Tools
4.4.1. Tools Market, 2018-2030 (USD Million)
4.5. Banks
4.5.1. Banks Market, 2018-2030 (USD Million)
4.6. Services
4.6.1. Services Market, 2018-2030 (USD Million)
Chapter 5. Therapeutic Category Business Analysis
5.1. Segment Dashboard
5.2. Global Regenerative Medicine Market: Therapeutic Category Movement Analysis
5.3. Dermatology
5.3.1. Dermatology Market, 2018-2030 (USD Million)
5.4. Musculoskeletal
5.4.1. Musculoskeletal Market, 2018-2030 (USD Million)
5.5. Immunology & Inflammation
5.5.1. Immunology & Inflammation Market, 2018-2030 (USD Million)
5.6. Oncology
5.6.1. Oncology Market, 2018-2030 (USD Million)
5.7. Cardiovascular
5.7.1. Cardiovascular Market, 2018-2030 (USD Million)
5.8. Ophthalmology
5.8.1. Ophthalmology Market, 2018-2030 (USD Million)
5.9. Others
5.9.1. Others Market, 2018-2030 (USD Million)
Chapter 6. Regional Business Analysis
6.1. Global Regenerative Medicine Market Share By Region, 2024 & 2030
6.2. North America
6.2.1. North America Regenerative Medicine Market, 2018-2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Competitive Scenario
6.2.2.3. Regulatory Framework
6.2.2.4. U.S. Regenerative Medicine Market, 2018-2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Competitive Scenario
6.2.3.3. Regulatory Framework
6.2.3.4. Canada Regenerative Medicine Market, 2018-2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Key Country Dynamics
6.2.4.2. Competitive Scenario
6.2.4.3. Regulatory Framework
6.2.4.4. Mexico Regenerative Medicine Market, 2018-2030 (USD Million)
6.3. Europe
6.3.1. Europe Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.2. Germany
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. Germany Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.3. UK
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. UK Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. France Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Competitive Scenario
6.3.5.3. Regulatory Framework
6.3.5.4. Italy Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Competitive Scenario
6.3.6.3. Regulatory Framework
6.3.6.4. Spain Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Competitive Scenario
6.3.7.3. Regulatory Framework
6.3.7.4. Denmark Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Competitive Scenario
6.3.8.3. Regulatory Framework
6.3.8.4. Sweden Regenerative Medicine Market, 2018-2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Competitive Scenario
6.3.9.3. Regulatory Framework
6.3.9.4. Norway Regenerative Medicine Market, 2018-2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. Japan Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. China Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. India Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.5. South Korea
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. South Korea Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.6. Australia
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Australia Regenerative Medicine Market, 2018-2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Thailand Regenerative Medicine Market, 2018-2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Regenerative Medicine Market, 2018-2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Brazil Regenerative Medicine Market, 2018-2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Argentina Regenerative Medicine Market, 2018-2030 (USD Million)
6.6. MEA
6.6.1. MEA Regenerative Medicine Market, 2018-2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. South Africa Regenerative Medicine Market, 2018-2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Saudi Arabia Regenerative Medicine Market, 2018-2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. UAE Regenerative Medicine Market, 2018-2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Kuwait Regenerative Medicine Market, 2018-2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.3. Company Market Position Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. AstraZeneca plc.
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. F. Hoffmann-La Roche Ltd.
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Integra Lifesciences Corp.
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Astellas Pharma, Inc.
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Cook Biotech, Inc.
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. Bayer AG
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Pfizer, Inc.
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. Merck KGaA
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Abbott
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Vericel Corp.
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives
7.4.11. Novartis AG
7.4.11.1. Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Strategic Initiatives
7.4.12. GlaxoSmithKline
7.4.12.1. Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Strategic Initiatives
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 4 Global Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 5 North America Regenerative Medicine Market, by Country, 2018-2030 (USD Million)
Table 6 North America Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 7 North America Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 8 U.S Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 9 U.S Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 10 Canada Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 11 Canada Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 12 Mexico Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 13 Mexico Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 14 Europe Regenerative Medicine Market, by Country, 2018-2030 (USD Million)
Table 15 Europe Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 16 Europe Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 17 Germany Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 18 Germany Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 19 U.K Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 20 U.K Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 21 France Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 22 France Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 23 Italy Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 24 Italy Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 25 Spain Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 26 Spain Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 27 Denmark Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 28 Denmark Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 29 Norway Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 30 Norway Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 31 Sweden Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 32 Sweden Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 33 Asia Pacific Regenerative Medicine Market, by Country, 2018-2030 (USD Million)
Table 34 Asia Pacific Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 35 Asia Pacific Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 36 China Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 37 China Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 38 Japan Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 39 Japan Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 40 India Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 41 India Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 42 Australia Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 43 Australia Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 44 South Korea Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 45 South Korea Regenerative Medicine Market, by services, 2018-2030 (USD Million)
Table 46 Thailand Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 47 Thailand Regenerative Medicine Market, by services, 2018-2030 (USD Million)
Table 48 Latin America Regenerative Medicine Market, by Country, 2018-2030 (USD Million)
Table 49 Latin America Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 50 Latin America Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 51 Brazil Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 52 Brazil Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 53 Argentina Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 54 Argentina Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 55 Middle East & Africa Regenerative Medicine Market, by Country, 2018-2030 (USD Million)
Table 56 Middle East & Africa Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 57 Middle East & Africa Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 58 South Africa Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 59 South Africa Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 60 Saudi Arabia Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 61 Saudi Arabia Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 62 UAE Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 63 UAE Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 64 Kuwait Regenerative Medicine Market, By Product, 2018-2030 (USD Million)
Table 65 Kuwait Regenerative Medicine Market, By Therapeutic Category, 2018-2030 (USD Million)
Table 66 Participant’s Overview
Table 67 Financial Performance
Table 68 Key Companies Undergoing Expansions
Table 69 Key Companies Undergoing Acquisitions
Table 70 Key Companies Undergoing Collaborations
Table 71 Key Companies Launching New Products/Services
Table 72 Key Companies Undergoing Partnerships
Table 73 Key Companies Undertaking Other Strategies
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary Others pattern
Figure 4 Market Others approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Market summary, 2024 (USD Million)
Figure 9 Market segmentation & scope
Figure 10 Market driver impact
Figure 11 Market restraint impact
Figure 12 Porter’s analysis
Figure 13 SWOT analysis
Figure 14 Global regenerative medicine therapeutics market, 2018-2030 (USD Million)
Figure 15 Global primary cell-bases therapeutics market, 2018-2030 (USD Million)
Figure 16 Global dermatology primary cell-bases therapeutics market, 2018-2030 (USD Million)
Figure 17 Global musculoskeletal primary cell-bases therapeutics market, 2018-2030 (USD Million)
Figure 18 Global surgical primary cell-bases therapeutics market, 2018-2030 (USD Million)
Figure 19 Global dental primary cell-bases therapeutics market, 2018-2030 (USD Million)
Figure 20 Global other primary cell-based therapeutics market, 2018-2030 (USD Million)
Figure 21 Global autologous stem cell & progenitor cell-based therapeutics market, 2018-2030 (USD Million)
Figure 22 Global autologous stem cell & progenitor cell-based therapeutics market, 2018-2030 (USD Million)
Figure 23 Global allogeneic stem cell & progenitor cell-based therapeutics market, 2018-2030 (USD Million)
Figure 24 Global other stem cell & progenitor cell-based therapeutics market, 2018-2030 (USD Million)
Figure 25 Global cell-based immunotherapies market, 2018-2030 (USD Million)
Figure 26 Global gene therapies market, 2018-2030 (USD Million)
Figure 27 Global regenerative medicines tools, 2018-2030 (USD Million)
Figure 28 Global banks market for regenerative medicine, 2018-2030 (USD Million)
Figure 29 Global regenerative medicine services market, 2018-2030 (USD Million)
Figure 30 Regenerative medicine market: Therapeutic category outlook and key takeaways
Figure 31 Regenerative medicine market: Therapeutic category movement analysis (USD Million)
Figure 32 Global dermatological therapeutics category market, 2018-2030 (USD Million)
Figure 33 Global musculoskeletal therapeutics category market, 2018-2030 (USD Million)
Figure 34 Global immunology & inflammation therapeutics category market, 2018-2030 (USD Million)
Figure 35 Global oncology therapeutics category market, 2018-2030 (USD Million)
Figure 36 Global cardiovascular therapeutics category market, 2018-2030 (USD Million)
Figure 37 Global ophthalmology therapeutics market, 2018-2030 (USD Million)
Figure 38 Global other therapeutics category market, 2018-2030 (USD Million)
Figure 39 Global Regenerative Medicine Market: Regional outlook and key takeaways
Figure 40 North America Regenerative Medicine Market, 2018-2030 (USD Million)
Figure 41 U.S key country dynamics
Figure 42 U.S Regenerative Medicine Market, 2018-2030 (USD Million)
Figure 43 Canada key country dynamics
Figure 44 Canada Regenerative Medicine Market, 2018-2030 (USD Million)
Figure 45 Mexico key country dynamics
Figure 46 Mexico Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Europe Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Germany key country dynamics
Figure 49 Germany Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 50 France key country dynamics
Figure 51 France Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 52 U.K key country dynamics
Figure 53 U.K Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Italy key country dynamics
Figure 55 Italy Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 56 Spain key country dynamics
Figure 57 Spain Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 58 Denmark key country dynamics
Figure 59 Denmark Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 60 Sweden key country dynamics
Figure 61 Sweden Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Norway key country dynamics
Figure 63 Norway Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 64 Asia-Pacific Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 65 China key country dynamics
Figure 66 China Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 67 India key country dynamics
Figure 68 India Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 69 South Korea key country dynamics
Figure 70 South Korea Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 71 Japan key country dynamics
Figure 72 Japan Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 73 Australia key country dynamics
Figure 74 Australia Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 75 Thailand key country dynamics
Figure 76 Thailand Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 77 Latin America Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Brazil key country dynamics
Figure 79 Brazil Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Argentina key country dynamics
Figure 81 Argentina Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 82 MEA Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 83 South Africa key country dynamics
Figure 84 South Africa Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 85 Saudi Arabia key country dynamics
Figure 86 Saudi Arabia Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 87 UAE key country dynamics
Figure 88 UAE Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 89 Kuwait key country dynamics
Figure 90 Kuwait Regenerative Medicine Market estimates and forecast, 2018-2030 (USD Million)
Figure 91 Market participant categorization
Figure 92 Strategy framework

Companies Mentioned

The major companies featured in this Regenerative Medicine market report include:
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd.
  • Integra Lifesciences Corp.
  • Astellas Pharma, Inc.
  • Cook Biotech, Inc.
  • Bayer AG
  • Pfizer, Inc.
  • Merck KGaA
  • Abbott
  • Vericel Corp.
  • Novartis AG
  • GlaxoSmithKline (GSK)

Table Information

Report AttributeDetails
No. of Pages245
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 35.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 90.01 Billion
Compound Annual Growth Rate16.8%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Regenerative Medicine Market by Product Type, Source, Application Areas, End User - Global Forecast to 2030 - Product Image

Regenerative Medicine Market by Product Type, Source, Application Areas, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Translational Regenerative Medicine Market by Product Type, Therapeutic Approach, Application, End User - Global Forecast to 2030 - Product Image

Translational Regenerative Medicine Market by Product Type, Therapeutic Approach, Application, End User - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Regenerative Medicine Market Report and Forecast 2024-2032 - Product Image

Regenerative Medicine Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Regenerative Medicine Market Report 2025-2033 - Product Image

Regenerative Medicine Market Report 2025-2033

  • Report
  • 125 Pages
  • Global
From
Regenerative Medicine Market by Product and Application - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Regenerative Medicine Market by Product and Application - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 220 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.